Image

Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Recruiting
18 years and older
All
Phase 1/2

Powered by AI

Overview

A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of d-MAPPS™ Ophthalmic Solution in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGHVD)

Eligibility

Inclusion Criteria:

  • Age ≥ 18 years.
  • Willing and able to provide written informed consent.
  • Willing and able to comply with study assessments for the full duration of the study.
  • Patients may be using bilateral scleral lenses and/or bilateral punctal plugs at the time of accrual.
  • Minimum Oxford Schema grad of ≥ 1 in at least one eye.
  • OSDI scored of ≥ 22.
  • UNC DEMS score of ≥ 3.
  • In good stable overall health.

Exclusion Criteria:

  • History of Rheumatoid Arthritis, Lupus, Scleroderma.
  • Ocular or periocular malignancy.
  • Significant change, as judged by the principal investigator, in systemic immunosuppressive regimen within 2 weeks of study entry.
  • Any history of topical tacrolimus use.
  • Any change in dosage of tetracycline compounds (tetracycline, doxycycline, and minocycline) within the last month.
  • Any change in frequency of preserved anti-glaucoma medications within 2 weeks of study entry.
  • Current use of topical steroids more than twice a day.
  • Corneal epithelial defect > 1mm2.
  • Any history of herpetic keratitis.
  • Participation in another simultaneous medical research study.
  • Signs of current infection, including fever and current treatment with antibiotics.
  • All vaccination including COVID are prohibited during this study.
  • Signs of current infection, including fever and current treatment with antibiotics.
  • All vaccinations including COVID are prohibited during this study.
  • Intra-ocular surgery or ocular laser surgery within 3 months.
  • Women who are pregnant, breastfeeding, or plan to become pregnant while participating in the study. If of childbearing potential, unwillingness to use effective birth control while participating in the study.
  • Any condition (including language barrier) that precludes patient's ability to comply with study requirements including completion of study.

Study details
    oGHVD

NCT06852768

Regenerative Ocular Immunobiologics LLC

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.